Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05797155 · ClinicalTrials.gov registry record · NA

A Mobile App Based Cognitive Dissonance Intervention for Smoking Cessation

A NA study of Tobacco Use, sponsored by Oregon Research Behavioral Intervention Strategies.

Completed
Registry status
NA
Development phase
437
Enrollment target
1
Study location

NCT05797155 is a NA study of Tobacco Use that has completed, run by Oregon Research Behavioral Intervention Strategies. The registered enrollment target is 437 participants, above the 373-participant average among 76 other Tobacco Use trials with a reported enrollment target (17% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05797155, a NA study of Tobacco Use, has completed, sponsored by Oregon Research Behavioral Intervention Strategies.

COMPLETED
Registry status
NA
Development phase
437 participants
Enrollment target
1
Study location

Study Summary

This research study aims to develop a cognitive dissonance-based mobile app for smoking cessation (Support2Quit) and test the efficacy of the app with 500 adult smokers who express a desire to quit smoking.

Conditions Studied

Interventions

  • BEHAVIORAL Support2Quit App - Cognitive Dissonance Based Smoking Cessation + Smoking Cessation Tips
  • BEHAVIORAL Tips for Smoking Cessation App

Study Locations (1)

Oregon

  • Oregon Research Behavioral Intervention Strategies, Inc. - Springfield

Trial Details

FieldValue
Enrollment Target 437 participants
Start Date 2023-12-01
Est. Completion 2025-03-15
Phase NA

What the Registry Record Tells You About NCT05797155

The ClinicalTrials.gov registry entry for NCT05797155 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 437 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 373-participant average among 76 other Tobacco Use trials with a reported enrollment target (17% higher). The listed sponsor is Oregon Research Behavioral Intervention Strategies, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tobacco Use appearing as the primary indexed condition, and to 2 interventions - of which Support2Quit App - Cognitive Dissonance Based Smoking Cessation + Smoking Cessation Tips is the first listed.

NCT05797155 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT05797155 about?

NCT05797155 is a clinical study titled "A Mobile App Based Cognitive Dissonance Intervention for Smoking Cessation". This research study aims to develop a cognitive dissonance-based mobile app for smoking cessation (Support2Quit) and test the efficacy of the app with 500 adult smokers who express a desire to quit smoking.

What is the current status of trial NCT05797155?

This trial is currently completed. It is a NA study. The enrollment target is 437 participants. The study started on 2023-12-01. Estimated completion is 2025-03-15.

What conditions does trial NCT05797155 study?

This clinical trial studies the following conditions: Tobacco Use.

What interventions are being tested in trial NCT05797155?

The interventions under investigation include: Support2Quit App - Cognitive Dissonance Based Smoking Cessation + Smoking Cessation Tips (BEHAVIORAL), Tips for Smoking Cessation App (BEHAVIORAL).

Who is sponsoring clinical trial NCT05797155?

This trial is sponsored by Oregon Research Behavioral Intervention Strategies, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05797155 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.